Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.33 USD | -1.03% | +0.31% | +1.81% |
07-02 | Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc. Appoints Patricia Drake as Chief Commercial Officer | CI |
06-18 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+1.81% | 1.02B | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- INVA Stock
- News Innoviva, Inc.
- Transcript : Theravance Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-16-2014 10